UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000017917
Receipt No. R000020770
Official scientific title of the study Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of the Plum Extract on the Improvement of Blood Pressure and Blood Flow
Date of disclosure of the study information 2015/06/16
Last modified on 2016/07/15 (Ver. 6)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Double-Blind, Placebo-Controlled Study for the Effect of Daily Ingestion of the Plum Extract on the Improvement of Blood Pressure and Blood Flow
Title of the study (Brief title) The Effect of Daily Ingestion of the Plum Extract on the improvement of Blood Pressure and Blood Flow
Region
Japan

Condition
Condition Healthy adults
Classification by specialty
Adult
Classification by malignancy Others
Genomic information YES

Objectives
Narrative objectives1 To prove the clinical usefulness of blood pressure and blood flow improvement by investigating effects from daily ingestion of plum extract for 12 weeks.
To evaluate the overall health promotion by secondarily examining effects of lipid metabolism, blood glucose, fatigue recovery and regulation of intestinal function.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2 Pragmatic
Developmental phase Phase III

Assessment
Primary outcomes systolic pressure and diastolic pressure (hospital pressure and home pressure) , peripheral blood flow
Key secondary outcomes T-Cho, HDL-Cho, LDL-Cho, TG,
fasting plasma glucose, HbA1c, hs-CRP, adiponectin, platelet aggregation, defecation frequency, VAS questionnaire

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Double blind -all involved are blinded
Control Placebo
Stratification YES
Dynamic allocation NO
Institution consideration Institution is not considered as adjustment factor.
Blocking YES
Concealment Central registration

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Food
Interventions/Control_1 Ingestion of the plum extract pill daily for 12 weeks
Interventions/Control_2 Ingestion of the placebo pill daily for 12 weeks
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
30 years-old <=
Age-upper limit
70 years-old >
Gender Male and Female
Key inclusion criteria 1. Subjects whose SBP is between 130mmHg and 160mmHg
2. Subjects who agree to participate in the current study with a written informed consent.
Key exclusion criteria 1. Subjects who are under treatment and medication for hypertension.
2. Subjects with serious cerebrovascular, cardiac, hepatic, renal, and / or gastrointestinal diseases, or affected with an infectious disease which is required to report to the authorities
3. Subjects who have a major surgical history related to digestive system such as gastrectomy, gastrorrhaphy, enterectomy, etc.
4. Subjects with unusually high and/or low blood pressure or abnormal hematological data
5. Subjects with serious anemia
6. Pre- or post-menopausal subjects having complaints of obvious physical changes
7. Subjects who are at risk of having allergic reactions to drugs or foods (especially plum)
8. Subjects regularly take medicine, functional foods and/or supplements ( peptide, acetic acid, GABA, geniposidic acid, flavonoids, sesamin, chlorella, olive leaves, garlics, dietary fiber, tomatoes, folic acid, etc.) which would affect the blood pressure.
9. Heavy smokers, alcohol addicts or subjects with irregular lifestyle
10. Subjects who donate either 400ml whole blood within 12 weeks or 200ml whole blood within 4 weeks or blood components within 2 weeks prior to this study.
11. Subjects who are pregnant or expected to be pregnant, or lactating during the study
12. Subjects who participate in other clinical trials within the last one month prior to the current clinical trial
13. Any other medical reasons judged by the principal investigator
Target sample size 52

Research contact person
Name of lead principal investigator Prof. Jun NISHIHIRA, M.D., Ph.D.
Organization Hokkaido Information University
Division name Department of Medical Management and Informatics
Address 59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
TEL 011-385-4411
Email nishihira@do-johodai.ac.jp

Public contact
Name of contact person Dir. Prof. Jun NISHIHIRA, M.D., Ph.D.
Organization Hokkaido Information University
Division name Center of Health Information Science
Address 59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
TEL 011-385-4430
Homepage URL
Email nishihira@do-johodai.ac.jp

Sponsor
Institute Hokkaido Information University
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization NAKANO.B.C. Co. Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 北海道情報大学 保健センター

Other administrative information
Date of disclosure of the study information
2015 Year 06 Month 16 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 05 Month 27 Day
Anticipated trial start date
2015 Year 07 Month 01 Day
Last follow-up date
2015 Year 11 Month 16 Day
Date of closure to data entry
2015 Year 12 Month 17 Day
Date trial data considered complete
2015 Year 12 Month 24 Day
Date analysis concluded
2016 Year 04 Month 08 Day

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 06 Month 16 Day
Last modified on
2016 Year 07 Month 15 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020770